What is Clomid?

Clomid 50mg from Cenzo Pharma (clomifene citrate) is an effective PCT drug used after a cycle of anabolic-androgenic steroids. It helps restore the body’s hormonal balance by restarting natural hormone production.

Uses

Clomid 50mg from Cenzo Pharma has multiple benefits.

  • Treats menstrual irregularities and other issues in women.
  • Solves reproductive issues to simplify the process of pregnancy.
  • Treats in Hypogonadism in males.
  • Effective PCT medication for treating steroid-cycle-induced hormonal imbalance.

Dosages

The dosages for Clomid 50mg from Cenzo Pharma might vary among different people as they are prescribed depending on one’s age, gender, and medical condition. So, it is important to get these prescribed by a licensed doctor

  • 20mg/day when starting after 3 days from the last dose of steroid.
  • 50mg/day if you start after 2 days from the last steroid dosage.
  • 100mg/day when starting just 1 day after the last steroid dose.

Side Effects

Clomid 50mg from Cenzo Pharma can result in a few potential side effects. So, it is better if one starts using the medication after knowing about these possible effects.

  • Constant mood swings
  • Pain in the pelvic region
  • Tumors in the testicles
  • Gynecomastia
  • Blurred vision and dizziness
  • Headache and hot flashes
  • Gastrointestinal issues like upset stomach, vomiting, and nausea
  • Tenderness and pain in the breast
  • Hypertriglyceridemia

Drug Interactions

Clomid 50mg from Cenzo Pharma can show a few interactions with certain medications.

  • Medicines for skin issues and allergies
  • Blood thinners
  • Insulin

Inform your doctor of your current list of medications.

Precautions

Clomid 50mg from Cenzo Pharma can only be bought with a legitimate prescription. Strictly stick to your prescribed dosages to avoid any chance of an overdose.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

No more offers for this product!

General Inquiries

There are no inquiries yet.